U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 49

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:1805658
GRCh38:
Chr4:1803931
FGFR3Achondroplasia, HypochondroplasiaPathogenic
(Sep 7, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr4:1805465
GRCh38:
Chr4:1803738
FGFR3L326WHypochondroplasiaLikely pathogeniccriteria provided, single submitter
3.
GRCh37:
Chr4:1807549
GRCh38:
Chr4:1805822
FGFR3P461L, P573L, P574L, P575LCervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia, type 2,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Colorectal cancer,
Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Epidermal nevus, Malignant tumor of urinary bladderHypochondroplasia,
Levy-Hollister syndrome, Germ cell tumor of testis, not provided,
...see more
Uncertain significance
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:1807494
GRCh38:
Chr4:1805767
FGFR3V443L, V555L, V556L, V557LHypochondroplasia, not providedConflicting interpretations of pathogenicity
(Sep 16, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr4:1801055
GRCh38:
Chr4:1799328
FGFR3P62SFGFR3-related disoder, Cervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome,
Colorectal cancer, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Epidermal nevusMalignant tumor of urinary bladder,
Hypochondroplasia, Levy-Hollister syndrome, Germ cell tumor of testis,
...see more
Uncertain significance
(Feb 1, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr4:1807915
GRCh38:
Chr4:1806188
FGFR3Epidermal nevus, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Cervix cancer, Levy-Hollister syndrome, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndromeHypochondroplasia,
Germ cell tumor of testis, Colorectal cancer, not provided,
...see more
Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr4:1807887
GRCh38:
Chr4:1806160
FGFR3K537R, K649R, K650R, K651RCervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia, type 2,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Colorectal cancer,
Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Epidermal nevus, Malignant tumor of urinary bladderHypochondroplasia,
Levy-Hollister syndrome, Germ cell tumor of testis, not provided,
...see more
Uncertain significance
(Jan 17, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr4:1807658
GRCh38:
Chr4:1805931
FGFR3Connective tissue disorder, Cervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome,
Colorectal cancer, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Epidermal nevusMalignant tumor of urinary bladder,
Hypochondroplasia, Levy-Hollister syndrome, Germ cell tumor of testis,
not provided, ...see more
Conflicting interpretations of pathogenicity
(Apr 14, 2022)
criteria provided, conflicting interpretations
9.
GRCh37:
Chr4:1806551
GRCh38:
Chr4:1804824
FGFR3V311L, V423L, V424L, V425LCervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia, type 2,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Colorectal cancer,
Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Epidermal nevus, Malignant tumor of urinary bladderHypochondroplasia,
Levy-Hollister syndrome, Germ cell tumor of testis, Inborn genetic diseases,
not provided, ...see more
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr4:1805531
GRCh38:
Chr4:1803804
FGFR3S348Cnot providedLikely pathogenic
(Feb 18, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr4:1807298
GRCh38:
Chr4:1805571
FGFR3D404G, D516G, D517G, D518GAchondroplasia, Crouzon syndrome-acanthosis nigricans syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Cervix cancer, Malignant tumor of urinary bladder, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testis, Levy-Hollister syndrome,
Muenke syndrome, HypochondroplasiaEpidermal nevus,
Colorectal cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, not provided,
...see more
Uncertain significance
(Jan 5, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr4:1806236
GRCh38:
Chr4:1804509
FGFR3L419F, L421Fnot provided, Achondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cervix cancer, Malignant tumor of urinary bladder,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Germ cell tumor of testis,
Levy-Hollister syndrome, Muenke syndromeHypochondroplasia,
Epidermal nevus, Colorectal cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
...see more
Uncertain significance
(Jul 20, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr4:1807863
GRCh38:
Chr4:1806136
FGFR3D529V, D641V, D642V, D643VHypochondroplasiaUncertain significance
(Jan 1, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr4:1807862-1807863
GRCh38:
Chr4:1806135-1806136
FGFR3D529I, D641I, D642I, D643IHypochondroplasiaUncertain significance
(Aug 16, 2017)
criteria provided, single submitter
15.
GRCh37:
Chr4:1803162
GRCh38:
Chr4:1801435
FGFR3V172Inot provided, Hypochondroplasia, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Aug 11, 2022)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr4:1808981
GRCh38:
Chr4:1807254
FGFR3A782V, R807W, R693W, R805W, R806WAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cervix cancer,
Colorectal cancer, Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Muenke syndrome, Hypochondroplasia, Germ cell tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of urinary bladderThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Epidermal nevus, not provided,
...see more
Uncertain significance
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr4:1805540
GRCh38:
Chr4:1803813
FGFR3S351Fnot provided, HypochondroplasiaPathogenic
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr4:1806615
GRCh38:
Chr4:1804888
FGFR3S444F, S446F, S332F, S445FInborn genetic diseasesUncertain significance
(Jan 29, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr4:1801071
GRCh38:
Chr4:1799344
FGFR3G67DCrouzon syndrome-acanthosis nigricans syndrome, Achondroplasia, Cervix cancer,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Malignant tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Thanatophoric dysplasia type 1, Malignant tumor of urinary bladder, Thanatophoric dysplasia, type 2,
Levy-Hollister syndrome, Muenke syndromeHypochondroplasia,
Epidermal nevus, Carcinoma of colon, not provided,
...see more
Conflicting interpretations of pathogenicity
(May 7, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr4:1808395
GRCh38:
Chr4:1806668
FGFR3N718S, N720S, N719S, N606SInborn genetic diseases, not provided, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Epidermal nevus, Carcinoma of colon,
Achondroplasia, Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Thanatophoric dysplasia type 1, HypochondroplasiaMalignant tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Cervix cancer, Muenke syndrome,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, ...see more
Uncertain significance
(Jul 9, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr4:1808017
GRCh38:
Chr4:1806290
FGFR3A667S, A665S, A553S, A666SAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Epidermal nevus,
Cervix cancer, Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome,
Malignant tumor of urinary bladder, Severe achondroplasia-developmental delay-acanthosis nigricans syndromeMalignant tumor of testis,
Carcinoma of colon, Hypochondroplasia, not provided,
...see more
Uncertain significance
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr4:1807977
GRCh38:
Chr4:1806250
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Epidermal nevus,
Germ cell tumor of testis, Cervix cancer, Crouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Malignant tumor of urinary bladderSevere achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Hypochondroplasia, not provided,
...see more
Benign/Likely benign
(Feb 15, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr4:1807371
Chr4:1807123
GRCh38:
Chr4:1805644
Chr4:1805396
FGFR3, FGFR3N540K, N542K, N428K, N541K, Q485R, Q487R, Q373R, Q486RThanatophoric dysplasia type 1Pathogenic
(Jun 1, 2009)
no assertion criteria provided
24.
GRCh37:
Chr4:1806119
Chr4:1806111
GRCh38:
Chr4:1804392
Chr4:1804384
FGFR3, FGFR3G380R, G382R, L377R, L379RAchondroplasiaPathogenic
(Feb 1, 2006)
no assertion criteria provided
25.
GRCh37:
Chr4:1801219
GRCh38:
Chr4:1799492
FGFR3Connective tissue disorder, Levy-Hollister syndrome, Malignant tumor of urinary bladder,
Epidermal nevus, Colorectal cancer, Achondroplasia,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Muenke syndrome, HypochondroplasiaCrouzon syndrome-acanthosis nigricans syndrome,
Germ cell tumor of testis, Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2,
not provided, not specified, ...see more
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr4:1806629
GRCh38:
Chr4:1804902
FGFR3P449S, P451S, P337S, P450SConnective tissue disorder, not specified, not provided,
Hypochondroplasia
Benign/Likely benign
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr4:1806131
GRCh38:
Chr4:1804404
FGFR3F384L, F386LAchondroplasia, Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer,
Cervix cancer, Muenke syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testisLevy-Hollister syndrome,
Malignant tumor of urinary bladder, Epidermal nevus, Connective tissue disorder,
not specified, not provided, Hypochondroplasia,
...see more
Benign/Likely benign
(Aug 1, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr4:1807876
GRCh38:
Chr4:1806149
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Muenke syndrome,
Thanatophoric dysplasia type 1, Germ cell tumor of testis, Thanatophoric dysplasia, type 2,
Epidermal nevus, Cervix cancer, Levy-Hollister syndrome,
Colorectal cancer, Crouzon syndrome-acanthosis nigricans syndromeHypochondroplasia,
Malignant tumor of urinary bladder, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, not provided,
...see more
Benign/Likely benign
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650T, K652T, K538T, K651TFGFR3-related condition, FGFR3-related disorder, Achondroplasia,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Malignant tumor of urinary bladder, Carcinoma of colon,
Cervix cancer, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Crouzon syndrome-acanthosis nigricans syndromeLevy-Hollister syndrome,
Muenke syndrome, Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2,
Epidermal nevus, not provided, ...see more
Pathogenic
(Aug 16, 2023)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr4:1805512
GRCh38:
Chr4:1803785
FGFR3G342CHypochondroplasiaPathogenic
(Aug 23, 2013)
no assertion criteria provided
31.
GRCh37:
Chr4:1808988
GRCh38:
Chr4:1807261
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Malignant tumor of urinary bladder,
Colorectal cancer, Germ cell tumor of testis, Cervix cancer,
Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Muenke syndromeThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Epidermal nevus, not provided,
...see more
Pathogenic
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr4:1801122
GRCh38:
Chr4:1799395
FGFR3S84LAchondroplasia, Hypochondroplasia, Levy-Hollister syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Muenke syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
not provided, Achondroplasia ...see more
Pathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr4:1803655
GRCh38:
Chr4:1801928
FGFR3Y278Cnot provided, Short staturePathogenic
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr4:1803657
GRCh38:
Chr4:1801930
FGFR3S279Cnot provided, AchondroplasiaPathogenic/Likely pathogenic
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr4:1807370
GRCh38:
Chr4:1805643
FGFR3N540S, N542S, N541S, N428SInborn genetic diseases, not provided, Hypochondroplasia,
Achondroplasia, Neurodevelopmental delay
Conflicting interpretations of pathogenicity
(Feb 23, 2023)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr4:1807889
GRCh38:
Chr4:1806162
FGFR3K650Q, K652Q, K651Q, K538Qnot provided, HypochondroplasiaPathogenic
(Jun 2, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr4:1807891
GRCh38:
Chr4:1806164
FGFR3K650N, K652N, K651N, K538NMalignant tumor of urinary bladder, Thanatophoric dysplasia, type 2, Achondroplasia,
Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia,
Levy-Hollister syndrome, Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Colorectal cancer, Epidermal nevusThanatophoric dysplasia type 1,
Muenke syndrome, Crouzon syndrome-acanthosis nigricans syndrome, not provided,
Hypochondroplasia, ...see more
Pathogenic/Likely pathogenic
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr4:1807891
GRCh38:
Chr4:1806164
FGFR3K650N, K652N, K538N, K651NHypochondroplasiaPathogenic
(Dec 1, 2000)
no assertion criteria provided
39.
GRCh37:
Chr4:1807363
GRCh38:
Chr4:1805636
FGFR3I538V, I540V, I426V, I539Vnot provided, HypochondroplasiaConflicting interpretations of pathogenicity
(May 24, 2023)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr4:1807370
GRCh38:
Chr4:1805643
FGFR3N540T, N542T, N428T, N541Tnot providedPathogenic/Likely pathogenic
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650M, K652M, K538M, K651MMalignant tumor of urinary bladder, Thanatophoric dysplasia, type 2, Achondroplasia,
Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia,
Levy-Hollister syndrome, Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Colorectal cancer, Epidermal nevusThanatophoric dysplasia type 1,
Muenke syndrome, Crouzon syndrome-acanthosis nigricans syndrome, not provided,
Hypochondroplasia, ...see more
Pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr4:1803571
GRCh38:
Chr4:1801844
FGFR3P250RInborn genetic diseases, FGFR3-related chondrodysplasia, Malignant tumor of urinary bladder,
Thanatophoric dysplasia, type 2, Achondroplasia, Germ cell tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia, Levy-Hollister syndrome,
Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndromeColorectal cancer,
Epidermal nevus, Thanatophoric dysplasia type 1, Muenke syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Craniofacial dysostosis, Seizure,
Infantile axial hypotonia, Coronal craniosynostosis, Generalized non-motor (absence) seizure,
Unilateral renal agenesis, Facial asymmetry, Craniosynostosis syndrome,
not provided, Muenke syndrome, Hypochondroplasia,
Achondroplasia, Abnormality of the nervous system, ...see more
Pathogenic/Likely pathogenic
(Mar 21, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr4:1803568
GRCh38:
Chr4:1801841
FGFR3S249CFGFR3-related condition, Connective tissue disorder, Malignant tumor of urinary bladder,
Thanatophoric dysplasia, type 2, Achondroplasia, Carcinoma of colon,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia, Levy-Hollister syndrome,
Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndromeMalignant tumor of testis,
Epidermal nevus, Thanatophoric dysplasia type 1, Muenke syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, not provided, Cervix cancer,
Malignant tumor of urinary bladder, Thanatophoric dysplasia type 1, ...see more
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N541K, N428KConnective tissue disorder, Inborn genetic diseases, Malignant tumor of urinary bladder,
Thanatophoric dysplasia, type 2, Achondroplasia, Carcinoma of colon,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia, Levy-Hollister syndrome,
Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndromeMalignant tumor of testis,
Epidermal nevus, Thanatophoric dysplasia type 1, Muenke syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, not provided, Larsen syndrome,
Hypochondroplasia, Achondroplasia, Short stature,
...see more
Pathogenic/Likely pathogenic
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N428K, N541Knot provided, Hypochondroplasia, Achondroplasia,
Neurodevelopmental delay
Pathogenic
(Aug 29, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr4:1808987
GRCh38:
Chr4:1807260
FGFR3V784ESevere achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome,
Achondroplasia, Colorectal cancer, Epidermal nevus,
Muenke syndrome, Cervix cancer, Germ cell tumor of testis,
Malignant tumor of urinary bladder, Levy-Hollister syndromeCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Hypochondroplasia, Thanatophoric dysplasia type 1, not provided,
...see more
Pathogenic
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr4:1803564
GRCh38:
Chr4:1801837
FGFR3R248CFGFR3-related condition, FGFR3-related chondrodysplasia, FGFR3-related disorder,
Connective tissue disorder, Malignant tumor of urinary bladder, Thanatophoric dysplasia, type 2,
Achondroplasia, Carcinoma of colon, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Hypochondroplasia, Levy-Hollister syndromeCervix cancer,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Malignant tumor of testis, Epidermal nevus,
Thanatophoric dysplasia type 1, Muenke syndrome, Crouzon syndrome-acanthosis nigricans syndrome,
not provided, Cervix cancer, Thanatophoric dysplasia, type 2,
Achondroplasia, Thanatophoric dysplasia type 1, Upper limb undergrowth,
Short stature, Disproportionate short-limb short stature, Lethal short-limbed short stature,
Lower limb undergrowth, Growth delay, Bowed humerus,
Small for gestational age, Skeletal dysplasia, Bell-shaped thorax,
Femoral bowing, Short ribs, Narrow chest,
Hamartoma, ...see more
Pathogenic
(Jul 1, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382Rnot provided, Hypochondroplasia, Achondroplasia
Pathogenic
(Dec 15, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382RFGFR3-Related Disorders, Connective tissue disorder, Inborn genetic diseases,
Malignant tumor of urinary bladder, Thanatophoric dysplasia, type 2, Achondroplasia,
Carcinoma of colon, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Hypochondroplasia,
Levy-Hollister syndrome, Cervix cancerCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Malignant tumor of testis, Epidermal nevus, Thanatophoric dysplasia type 1,
Muenke syndrome, Crouzon syndrome-acanthosis nigricans syndrome, not specified,
not provided, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Hypochondroplasia, ...see more
Pathogenic
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination